View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Liver/Biliary Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 14, 2023
3 min read
Save

Binge drinking, genetic predisposition linked to sixfold higher risk for cirrhosis

Binge drinking, genetic predisposition linked to sixfold higher risk for cirrhosis

Heavy binge drinking and high polygenic risk score were associated with a sixfold higher relative excess risk for alcohol-related cirrhosis, with the presence of diabetes mellitus further increasing the risk, researchers reported.

SPONSORED CONTENT
December 14, 2023
2 min read
Save

Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease

Researchers advise limit of 7.4 grams of alcohol per day in early steatotic liver disease

Researchers recommended that patients with steatotic liver disease who are at a lower risk for advanced cirrhosis should consume no more than 7.4 grams of alcohol per day, the equivalent of a half a 12 oz. beer or half a glass of wine.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
December 13, 2023
2 min watch
Save

VIDEO: Interim INTEGRIS-PSC trial results ‘promising’ in primary sclerosing cholangitis

VIDEO: Interim INTEGRIS-PSC trial results ‘promising’ in primary sclerosing cholangitis

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about interim results from the phase 2a INTEGRIS-PSC trial presented at The Liver Meeting, which showed bexotegrast reduced biomarkers of liver fibrosis vs. placebo.

SPONSORED CONTENT
December 13, 2023
1 min watch
Save

VIDEO: Preclinical research investigates role of Claudin-1 in cholangiocarcinoma

VIDEO: Preclinical research investigates role of Claudin-1 in cholangiocarcinoma

BOSTON — Healio spoke with James L. Boyer, MD, FACEP, about research assessing the role of Claudin-1 in cholangiocarcinoma, which was presented at The Liver Meeting.

SPONSORED CONTENT
December 13, 2023
2 min read
Save

Novel therapies targeting bile acid-triggered pathways may benefit children with NASH

Novel therapies targeting bile acid-triggered pathways may benefit children with NASH

Medications that target bile acid-triggered pathways and combination therapies could be the key for treating nonalcoholic steatohepatitis for young people with obesity and type 2 diabetes, according to a speaker.

SPONSORED CONTENT
December 13, 2023
2 min read
Save

Liver transplant rates for HCC decline across all races after 2015 MELD policy change

Liver transplant rates for HCC decline across all races after 2015 MELD policy change

Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.

SPONSORED CONTENT
December 08, 2023
2 min read
Save

More education needed to help PCPs ‘feel confident’ treating, managing MASLD

More education needed to help PCPs ‘feel confident’ treating, managing MASLD

BOSTON — Although primary care physicians play a vital role in managing metabolic dysfunction-associated steatotic liver disease, many are not following guidance on screening, risk stratification or referrals, according to research.

SPONSORED CONTENT
December 07, 2023
1 min read
Save

Patients with MASLD lost less weight after bariatric surgery, study finds

Patients with MASLD lost less weight after bariatric surgery, study finds

BOSTON — Patients with metabolic dysfunction-associated steatotic liver disease who underwent bariatric surgery lost less weight over 5 years than those without MASLD, according to research presented at The Liver Meeting.

SPONSORED CONTENT
December 07, 2023
2 min read
Save

Tenofovir disoproxil linked to better long-term outcomes vs. entecavir in HBV-related HCC

Tenofovir disoproxil linked to better long-term outcomes vs. entecavir in HBV-related HCC

Tenofovir disoproxil improved long-term overall and recurrence-free survival rates compared with entecavir among patients with hepatitis B virus-related hepatocellular carcinoma who underwent liver resection.

SPONSORED CONTENT
December 07, 2023
2 min read
Save

Women with food insecurity, low BMI more likely to have hepatic steatosis

Women with food insecurity, low BMI more likely to have hepatic steatosis

BOSTON — Women who experience food insecurity and have a BMI less than 25 kg/m2 had higher odds of hepatic steatosis compared with overweight women or those with obesity, regardless of HIV status, according to research at The Liver Meeting.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails